Potential protein phosphatase 2A agents from traditional Chinese medicine against cancer

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Chen, Kuan Chung ^a   Chen, Hsin Yi ^b   Chen, Calvin Yu Chian ^b,c,d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b ASIA UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d Massachusetts Institute of Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGELIFERULATE; DICHOTOMOSIDE E; PHOSPHOPROTEIN PHOSPHATASE 2A; SQUAMOSAMIDE; TRICHOSANATINE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CHINESE MEDICINE; DRUG POTENTIATION; HYDROGEN BOND; LIGAND BINDING; MOLECULAR DOCKING; MOLECULAR DYNAMICS; NEOPLASM; PROTEIN TARGETING;

EID: 84901277102     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/436863     Document Type: Article

References (47)

1. Porter I. M., Schleicher K., Porter M., Swedlow J. R., Bod1 regulates protein phosphatase 2A at mitotic kinetochores. Nature Communications 2013 4 article 2677 10.1038/ncomms3677
2. Wera S., Hemmings B. A., Serine/threonine protein phosphatases. The Biochemical Journal 1995 311 part 1 17 29 2-s2.0-0029129557
3. Mumby M. C., Walter G., Protein serine/threonine phosphatases: structure, regulation, and functions in cell growth. Physiological Reviews 1993 73 4 673 699 2-s2.0-0027143725 (Pubitemid 24004649)
4. Janssens V., Goris J., Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. The Biochemical Journal 2001 353 part 3 417 439 2-s2.0-0035252894 10.1042/0264-6021:3530417 (Pubitemid 32158309)
5. Virshup D. M., Protein phosphatase 2A: a panoply of enzymes. Current Opinion in Cell Biology 2000 12 2 180 185 2-s2.0-0034009389 10.1016/S0955- 0674(99)00074-5 (Pubitemid 30142564)
6. Ruediger R., Hentz M., Fait J., Mumby M., Walter G., Molecular model of the A subunit of protein phosphatase 2A: interaction with other subunits and tumor antigens. Journal of Virology 1994 68 1 123 129 2-s2.0-0028082299
7. Calin G. A., di Iasio M. G., Caprini E., Vorechovsky I., Natali P. G., Sozzi G., Croce C. M., Barbanti-Brodano G., Russo G., Negrini M., Low frequency of alterations of the α (PPP2R1A) and β (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms. Oncogene 2000 19 9 1191 1195 2-s2.0-0034708257 (Pubitemid 30157549)
8. Ruediger R., Pham H. T., Walter G., Disruption of protein phosphatase 2A subunit interaction in human cancers with mutations in the A α subunit gene. Oncogene 2001 20 1 10 15 2-s2.0-0035804217 (Pubitemid 32142333)
9. Bialojan C., Takai A., Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. Biochemical Journal 1988 256 1 283 290 2-s2.0-0023691731
10. Chen W., Wang Z., Jiang C., Ding Y., PP2A-mediated anticancer therapy. Gastroenterology Research and Practice 2013 2013 10 675429 10.1155/2013/675429
11. Schönthal A. H., Role of serine/threonine protein phosphatase 2A in cancer. Cancer Letters 2001 170 1 1 13 2-s2.0-0035840446 10.1016/S0304-3835(01) 00561-4 (Pubitemid 32607654)
12. Jiang Y., Li X., Yang W., Hawke D. H., Zheng Y., Xia Y., Aldape K., Wei C., Guo F., Chen Y., Lu Z., PKM2 regulates chromosome segregation and mitosis progression of tumor cells. Molecular Cell 2014 53 1 75 87 10.1016/j.molcel. 2013.11.001
13. Chou I.-C., Lin W.-D., Wang C.-H., Chang Y.-T., Chin Z.-N., Tsai C.-H., Tsai F.-J., Association analysis between Tourette's syndrome and two dopamine genes (DAT1, DBH) in Taiwanese children. BioMedicine 2013 3 2 88 91 10.1016/j.biomed.2013.02.003
14. Yamamoto T., Hung W.-C., Takano T., Nishiyama A., Genetic nature and virulence of community-associated methicillin-resistant Staphylococcus aureus. BioMedicine 2013 3 1 2 18 10.1016/j.biomed.2012.12.001
15. Wang C.-H., Lin W.-D., Bau D.-T., Choua I.-C., Tsai C.-H., Tsai F.-J., Appearance of acanthosis nigricans may precede obesity: an involvement of the insulin/IGF receptor signaling pathway. BioMedicine 2013 3 2 82 87
16. Chang Y.-M., Velmurugan B. K., Kuo W.-W., Chen Y.-S., Ho T.-J., Tsai C.-T., Ye C.-X., Tsai C.-H., Tsai F.-J., Huang C.-Y., Inhibitory effect of alpinate Oxyphyllae fructus extracts on Ang II-induced cardiac pathological remodeling-related pathways in H9c2 cardiomyoblast cells. BioMedicine 2013 3 4 148 152
17. 2+ store-depleted rat insulinoma RINm5F cells. BioMedicine 2013 3 3 130 139
18. Mahamuni S. P., Khose R. D., Menaa F., Badole S. L., Therapeutic approaches to drug targets in hyperlipidemia. BioMedicine 2012 2 4 137 146
19. Jao C.-L., Huang S.-L., Hsu K.-C., Angiotensin I-converting enzyme inhibitory peptides: inhibition mode, bioavailability, and antihypertensive effects. BioMedicine 2012 2 4 130 136
20. Lin M.-C., Tsai S.-Y., Wang F.-Y., Liu F.-H., Syu J.-N., Tang F.-Y., Leptin induces cell invasion and the upregulation of matrilysin in human colon cancer cells. BioMedicine 2013 3 4 174 180
21. Su K.-P., Inflammation in psychopathology of depression: clinical, biological, and therapeutic implications. BioMedicine 2012 2 2 68 74 2-s2.0-84860591476 10.1016/j.biomed.2012.03.002
22. Leissring M. A., Malito E., Hedouin S., Reinstatler L., Sahara T., Abdul-Hay S. O., Choudhry S., Maharvi G. M., Fauq A. H., Huzarska M., May P. S., Choi S., Logan T. P., Turk B. E., Cantley L. C., Manolopoulou M., Tang W.-J., Stein R. L., Cuny G. D., Selkoe D. J., Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin. PLoS ONE 2010 5 5 e10504 2-s2.0-77956274306 10.1371/journal.pone.0010504
23. Chen C.-Y., Chen C. Y.-C., Insights into designing the dual-targeted HER2/HSP90 inhibitors. Journal of Molecular Graphics & Modelling 2010 29 1 21 31 2-s2.0-77955772552 10.1016/j.jmgm.2010.04.002
24. Yang S.-C., Chang S.-S., Chen H.-Y., Chen C. Y.-C., Identification of potent EGFR inhibitors from TCM database@Taiwan. PLoS Computational Biology 2011 7 10 2-s2.0-80055077153 10.1371/journal.pcbi.1002189 e1002189
25. Tsou Y. A., Chen K. C., Lin H. C., Chang S. S., Chen C. Y. C., Uroporphyrinogen decarboxylase as a potential target for specific components of traditional Chinese medicine: a virtual screening and molecular dynamics study. PLoS ONE 2012 7 11 e50087 10.1371/journal.pone.0050087
26. Tsou Y. A., Chen K. C., Chang S. S., Wen Y. R., Chen C. Y., A possible strategy against head and neck cancer: in silico investigation of three-in-one inhibitors. Journal of Biomolecular Structure & Dynamics 2013 31 12 1358 1369 10.1080/07391102.2012.736773
27. Chen K. C., Chang S. S., Tsai F. J., Chen C. Y., Han ethnicity-specific type 2 diabetic treatment from traditional Chinese medicine? Journal of Biomolecular Structure & Dynamics 2013 31 11 1219 1235
28. Chen K.-C., Sun M.-F., Yang S.-C., Chang S.-S., Chen H.-Y., Tsai F.-J., Chen C. Y.-C., Investigation into potent inflammation inhibitors from traditional Chinese medicine. Chemical Biology & Drug Design 2011 78 4 679 688 2-s2.0-80052619174 10.1111/j.1747-0285.2011.01202.x
29. Chang S.-S., Huang H.-J., Chen C. Y.-C., Two birds with one stone? Possible dual-targeting H1N1 inhibitors from traditional Chinese medicine. PLoS Computational Biology 2011 7 12 2-s2.0-84855282742 10.1371/journal.pcbi.1002315 e1002315
30. Chen K. C., Chang S. S., Huang H. J., Lin T. L., Wu Y. J., Chen C. Y., Three-in-one agonists for PPAR-alpha, PPAR-gamma, and PPAR-delta from traditional Chinese medicine. Journal of Biomolecular Structure & Dynamics 2012 30 6 662 683
31. Chen K.-C., Yu-Chian Chen C., Stroke prevention by traditional Chinese medicine? A genetic algorithm, support vector machine and molecular dynamics approach. Soft Matter 2011 7 8 4001 4008 2-s2.0-79953746295 10.1039/c0sm01548b
32. Chen K.-C., Chang K.-W., Chen H.-Y., Chen C. Y.-C., Traditional Chinese medicine, a solution for reducing dual stroke risk factors at once? Molecular BioSystems 2011 7 9 2711 2719 2-s2.0-80051760684 10.1039/c1mb05164d
33. Chang T.-T., Chen K.-C., Chang K.-W., Chen H.-Y., Tsai F.-J., Sun M.-F., Chen C. Y.-C., In silico pharmacology suggests ginger extracts may reduce stroke risks. Molecular BioSystems 2011 7 9 2702 2710 2-s2.0-80051767195 10.1039/c1mb05228d
34. Huang H. J., Jian Y. R., Chen C. Y., Traditional Chinese medicine application in HIV: an in silico study. Journal of Biomolecular Structure & Dynamics 2014 32 1 1 12
35. Tou W. I., Chang S. S., Lee C. C., Chen C. Y., Drug design for neuropathic pain regulation from traditional Chinese medicine. Scientific Reports 2013 3 article 844 10.1038/srep00844
36. Chen K. C., Jian Y. R., Sun M. F., Chang T. T., Lee C. C., Chen C. Y., Investigation of silent information regulator 1 (Sirt1) agonists from Traditional Chinese Medicine. Journal of Biomolecular Structure & Dynamics 2013 31 11 1207 1218
37. Chen C. Y.-C., TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening in silico. PLoS ONE 2011 6 1 2-s2.0-79251561193 10.1371/journal.pone.0015939 e15939
38. Tou W. I., Chen C. Y., May disordered protein cause serious drug side effect? Drug Discovery Today 2013 10.1016/j.drudis.2013.10.020
39. Chen C. Y., Tou W. I., How to design a drug for the disordered proteins? Drug Discovery Today 2013 18 19-20 910 915 10.1016/j.drudis.2013.04.008
40. Xu Z., Cetin B., Anger M., Cho U. S., Helmhart W., Nasmyth K., Xu W., Structure and function of the PP2A-shugoshin interaction. Molecular Cell 2009 35 4 426 441 2-s2.0-68949206308 10.1016/j.molcel.2009.06.031
41. Xue B., Dunbrack R. L., Williams R. W., Dunker A. K., Uversky V. N., PONDR-FIT: a meta-predictor of intrinsically disordered amino acids. Biochimica et Biophysica Acta 2010 1804 4 996 1010 2-s2.0-76849087968 10.1016/j.bbapap. 2010.01.011
42. Brooks B. R., Bruccoleri R. E., Olafson B. D., States D. J., Swaminathan S., Karplus M., CHARMM: a program for macromolecular energy minimization and dynamics calculations. Journal of Computational Chemistry 1983 4 187 217
43. Lipinski C. A., Lombardo F., Dominy B. W., Feeney P. J., Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews 2001 46 1-3 3 26 2-s2.0-0035289779 10.1016/S0169-409X(00)00129-0 (Pubitemid 33653411)
44. Venkatachalam C. M., Jiang X., Oldfield T., Waldman M., LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites. Journal of Molecular Graphics and Modelling 2003 21 4 289 307 2-s2.0-0037212102 10.1016/S1093-3263(02)00164-X (Pubitemid 35441326)
45. Hess B., Kutzner C., van der Spoel D., Lindahl E., GRGMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. Journal of Chemical Theory and Computation 2008 4 3 435 447 2-s2.0-46249092554 10.1021/ct700301q
46. Zoete V., Cuendet M. A., Grosdidier A., Michielin O., SwissParam: a fast force field generation tool for small organic molecules. Journal of Computational Chemistry 2011 32 11 2359 2368 2-s2.0-79958841703 10.1002/jcc.21816
47. Fletcher R., Optimization 1969 New York, NY, USA Academic Press